Your email has been successfully added to our mailing list.

×
0 0 0 0 0.00591957542355581 0.00591957542355581 0.0122473974280466 0.00326597264747915
Stock impact report

Regeneron Pharmaceuticals misses top-line and bottom-line estimates; updates FY24 outlook [Seeking Alpha]

Sanofi - American Depositary Shares (SNY) 
US:NYSE Investor Relations: sanofi.com/en/investors
Company Research Source: Seeking Alpha
First quarter 2024 Dupixent global net sales (recorded by Sanofi) increased 24% to $3.08 billion versus first quarter 2023. First quarter Recommended For You More Trending News Recommended For You More Trending News About REGN Stock Related Stocks Trending Analysis Trending News Show less Read more
Impact Snapshot
Event Time:
SNY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for SNY alerts
Opt-in for
SNY alerts

from News Quantified
Opt-in for
SNY alerts

from News Quantified